British American Tobacco (BTI) Outlook Remains Positive at UBS Despite FDA Uncertainty
UBS maintains Buy on British American Tobacco (NYSE: BTI).Analyst Nik Oliver says the recent FDA uncertainty ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
